IRS Finalizes Anti-Inversion Regs That Sank $160B Pfizer Deal
The Internal Revenue Service implemented regulations Wednesday that a federal court had invalidated last October after they sank a planned $160 billion merger between Pfizer Inc. and Allergan PLC of Ireland....To view the full article, register now.
Already a subscriber? Click here to view full article